30 Jun 2006 ... Dasatinib is a leukemia treatment that works by blocking certain growth ... Informationen der Deutschen Leukämie- und Lymphom-Hilfe eV. 15. Febr. 2010 ... Übersicht aller Medikamente, Arzneimittel mit dem Wirkstoff Dasatinib. von F Journe - 2008 - Zitiert durch: 19 Apr 2009 ... Dasatinib ist bei allen CML-Stadien angezeigt und zudem bei Erwachsenen mit ...

9 Feb 2010 ... 17 Oct 2009 ... dasatinib (CHEBI:49375) has role protein kinase inhibitor (CHEBI:37699) ... dasatinib (CHEBI:

29 Jun 2006 ... Dasatinib may cause fetal harm. Sexually active male/female patients taking Sprycel should use adequate contraception.

Dasatinib and nilotinib for imatinib-intolerant chronic myeloid leukaemia ...

16 Jun 2009 ... 2 Jun 2007 ... Alle Berichte zum Thema dasatinib auf innovations-report.de, dem Forum für Innovationen, Wissenschaft, Forschung, Industrie und Wirtschaft. von M Talpaz - 2006 - Zitiert durch: Dasatinib - Dasatinib is a cancer medication that slows the growth and spread of cancer cells in the body. 29 Mar 2007 ...

23 Jul 2006 ... Dasatinib is a type of medication called a tyrosine kinase inhibitor.

Dasatinib Side Effects: patient, 69 years of age, was diagnosed with ... Health Professional from GERMANY reported Dasatinib side effect on Dec 21, 2006.

1 Nov 2009 ... Dasatinib is used to prevent and stop the growth of cancer cells ... Dasatinib helps your body stop making these abnormal white blood cells. 10 Mar 2009 ... RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Dateiformat: Mit Dasatinib steht seit dem Jahr 2006 eine potente Zweitlinientherapie für die Behandlung der chronischen myeloischen Leukämie (CML) zur Verfügung: von A Bergeron - 2007 - Zitiert durch: Dasatinib hemmt die Aktivität der BCR-ABLKinase, der Kinasen der SRC-Familie ... Dasatinib bindet an die aktive und inaktive Konformation der BCR-ABLKinase.

27 Mar 2009 ... This page tells you about the possible side effects of dasatinib. 17. Dez. 2006 ... Mit einiger Spannung warteten Patienten auf die Ergebnisse der Studien mit Dasatinib (Handelsname Sprycel). Based on modeling studies, dasatinib is predicted to bind to multiple conformations of the ABL kinase. von S Nam - 2007 - Zitiert durch: 19 Nov 2007 ... Dasatinib is an ABL tyrosine kinase inhibitor. News and project information on the Dasatinib - Tyrosine Kinase Inhibitor for Chronic Myeloid Leukaemia (CML).

The most common adverse effects of dasatinib include fluid retention, ... Dasatinib is a targeted therapy called a tyrosine kinase inhibitor. von DG Aguilera - 2009 - Zitiert durch: Dasatinib is a prescription drug used for the treatment of adults with chronic myeloid leukemia (CML). Dasatinib:Dasatinib medicine. ... Dasatinib Hersteller & Lieferanten auf Alibaba .com. Taizhou hikong chemical sell Dasatinib Monohydrate (CAS 302962-49-8) Market ... Dasatinib monohydrate (CAS 863127-77-9) Market Research Report 2010: .

Die medikamentöse CML-Therapie beginnt in der Regel mit dem Tyrosinkinasehemmer Imatinib.

This drug is a tyrosine kinase inhibitor that targets Bcr-Abl,Kit, PDGFR and Src . Dateiformat: Find patient medical information for Dasatinib Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Dasatinib Brand names: Sprycel™ Drug Forms: Dasatinib Tablets (below) Dasatinib Oral tablet Español: Dasatinib, Tableta oral Dasatinib Tablets.

Dasatinib binds to and inhibits the growth-promoting activities of these kinases .

21 Jan 2009 ... Dasatinib is a targeted therapy and is classified as a signal transduction inhibitor - tyrosine kinase inhibitor. 11 Aug 2009 ... INCOMPLETE structural diagram of dasatinib. Structure is missing a Chlorine, specifically the 2-Chloro off the 6-Methyl-phenyl group. Please refer to the following web address for up-to-date information: http://www .bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/dasatinib.htm. 20. Juni 2005 ... Ein neuer Tyrosinkinase-Hemmstoff könnte in Zukunft zum Rettungsanker für Kranke mit chronisch-myeloischer Leukämie (CML) werden. Sprycel (dasatinib) ist das erste genehmigte Mundtyrosinkinasehemmnis, das erwartet wird, ... Sprycel (dasatinib) kann fötalen Schaden verursachen.

11 Feb 2009 ... A Proposal for BMS-354825 (Dasatinib) in GISTJon Trent, MD, PhD Assistant Professor Dept.

Dateiformat:

München - Senior Fachkraft / Projektleiter für forschende pharmazeutische Industrie bei Bristol-Myers Squibb - für folgende Regionen: Region 04:

von J Cortes - 2007 - Zitiert durch: Stage 4 neuroblastoma (NB) is a devastating childhood cancer whose poor outcome has remained essentially unchanged in the last 20 years. 24 Apr 2008 ... Sprycel or Dasatinib is tyrosine kinase inhibitor. 12 Dec 2006 ... Sprycel tablets contain the active ingredient dasatinib, which is a type of anticancer medicine called a protein tyrosine kinase inhibitor.

3 Dec 2009 ... von A Bergeron - 2007 - Zitiert durch: Dasatinib, also known as BMS-354825, is a cancer drug produced by Bristol-Myers Squibb and sold under the trade name Sprycel. 4 Jan 2010 ... 26. Juli 2007 ... 58000, Reagenzienkit für die HPLC-Analytik von Imatinib, Norimatinib, Dasatinib und Nilotinib im Plasma/Serum. Für 100 Bestimmungen.

Dateiformat: Dasatinib is an orally bioavailable synthetic small molecule-inhibitor of SRC- family protein-tyrosine kinases. Dasatinib plus capecitabine (Cap) for progressive advanced breast cancer (ABC): Phase I study CA180004. To learn more about SPRYCEL® (dasatinib) visit our official website. Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinases inhibitor approved for use in patients with chronic myelogenous leukemia (CML). Haorui Pharma-Chem Inc. is an Active Pharmaceutical Ingredients (APIs) supplier.

9 Dec 2007 ... The two medications are dasatinib, the Bristol-Myers Squibb drug known as Sprycel®, and nilotinib, the Novartis drug known as Tasigna®.

Dateiformat:

22. Febr. 2007 ... Bristol-Myers Squibb SA: indications This drug is used to treat chronic myelogenous leukemia, accelerated blast crisis, and chronic phase and acute lymphoblastic leukemia.

Dateiformat:

Dateiformat:

Determining relevant targets of promiscuous kinase inhibitors has proven difficult. 3 Aug 2009 ... Physician reviewed dasatinib patient information - includes dasatinib description, dosage and directions.

INFORM: Welche Behandlungsdaten mit Dasatinib gibt es bisher? ... was zu einer Zulassung von Dasatinib unter dem Handelsnamen Sprycel® *1) geführt hat.

SPRYCEL® (dasatinib). For more information regarding SPRYCEL reimbursement, call 1-800-861-0048. Reimbursement specialists are available live from 7:

dasatiinib wasatinib dasayinib dasatjnib dasatibib dasatinub dasatineb dasatin7b dasatiniib dasatonib dsaatinib dosatinib daasatinib dadatinib daxatinib dasatinibb dasaginib dasainib dzsatinib dsatinib dawatinib daaatinib dasa4inib daastinib dasatigib dxsatinib adsatinib dasatinkb desatinib dusatinib dasat7nib dasatinnib dasotinib dasatin9b dasafinib dasatknib dasxtinib dasatinlb sasatinib dasatniib dasatin8b dasatinb dasitinib dasattinib dasat9nib dasatini dastainib dassatinib dasatnib dwsatinib dasatinin daeatinib dasatiniv rasatinib dasatimib dasatinbi xasatinib dasatinih dasatinig dasatinif easatinib dasa5inib dasaatinib ddasatinib vasatinib dasqtinib dasatijib dasahinib dasatlnib dasetinib dasatinab dasarinib fasatinib dasatinjb dasaitnib dasa6inib asatinib dasatinob dasatihib dacatinib dqsatinib dasatiinb dasatunib dasstinib dasztinib dasatanib dasat8nib casatinib dasatiib dastinib dasatenib disatinib dssatinib daqatinib daatinib dasutinib daswtinib dazatinib